Clinical Trial Update: To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update announces the Phase I study of JSKN016 in Chinese patients with advanced malignant solid tumors and indicates recruitment is underway…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• JSKN016

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Advanced Malignant Solid Tumor | Phase 1 | Status: RECRUITING